Utah sues Lilly over Zyprexa marketing
Pharma Compliance Alert, May 23, 2007
Utah became the latest state to sue Eli Lilly for allegedly misrepresenting the risks of the antipsychotic drug Zyprexa. The lawsuit also accuses the company of persuading doctors to prescribe Zyprexa for off-label uses such as anorexia and Alzheimer's, reports the Associated Press.
Attorney General Mark Shurtleff filed the lawsuit, in which the state seeks civil damages and penalties, including Medicaid losses for inappropriate prescriptions. In fact, the state is seeking $5,000 to $10,000 for each medically unnecessary prescription.
Short take: Purdue CIA
Last week we reported that Purdue Pharma and its president, chief legal officer, and former chief medical officer pleaded guilty to misbranding OxyContin. Now, the OIG has posted its corporate integrity agreement with the company. Go to the OIG's Web site to read it.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Case Management Monthly, June 2012
- Searched